Venova is creating a unique method of birth control for women that is long-acting, extremely effective, and free of adverse effects.
Venova Technologies has raised $2.2M in total funding. The most recent round was Grant. The last funding was announced in July 2025.
Venova Technologies's investors include National Institutes of Health.
Venova Technologies is headquartered in Cambridge, United States.
Venova is creating a unique method of birth control for women that is long-acting, extremely effective, and free of adverse effects.
Venova Technologies is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Venova Technologies — Funding & Investors." VCBacked, July 25, 2025, https://www.vcbacked.co/company/venova-technologies. Accessed October 28, 2026.
VCBacked. (2025). Venova Technologies — Funding & Investors. Retrieved October 28, 2026, from https://www.vcbacked.co/company/venova-technologies
{{cite web |title=Venova Technologies — Funding & Investors |url=https://www.vcbacked.co/company/venova-technologies |website=VCBacked |access-date=October 28, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated